close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

AZN.UK

13,576

+0.76%↑

GSK

1,802

-1.56%↓

AZN.UK

13,576

+0.76%↑

GSK

1,802

-1.56%↓

AZN.UK

13,576

+0.76%↑

GSK

1,802

-1.56%↓

AZN.UK

13,576

+0.76%↑

GSK

1,802

-1.56%↓

AZN.UK

13,576

+0.76%↑

GSK

1,802

-1.56%↓

Kodu・Aktsiate loetelu・Oxford Biomedica PLC
Search

Oxford Biomedica PLC

Suletud

617 0.33

Tugev "osta" hinnang

Hinna uuendus 5. dets 2025, 16:28 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

603

Max

623

Põhinäitajad

By Trading Economics

Sissetulek

-16M

-26M

Müük

-4.8M

73M

Aktsiakasum

-0.11

Kasumimarginaal

-36

Töötajad

900

EBITDA

-11M

-6.1M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+12.81% upside

Turustatistika

By TradingEconomics

Turukapital

74M

745M

Eelmine avamishind

616.67

Eelmine sulgemishind

617

Oxford Biomedica PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. dets 2025, 20:41 UTC

Tulu
Suurimad hinnamuutused turgudel

America's Car-Mart Rises on Better-Than-Expected 2Q Revenue, $300 Million Term Loan

DJ

Loe

4. dets 2025, 18:14 UTC

Omandamised, ülevõtmised, äriostud

Big Yellow Says It Will Terminate Takeover Talks With Blackstone

DJ

Loe

4. dets 2025, 17:43 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

Brera Holdings Signs Non-Binding Term Sheet to Acquire RockawayX

DJ

Loe

4. dets 2025, 17:01 UTC

Tulu

TD Bank Pushes Up Dividend After Underlying Earnings, Revenue Beat Expectations -- Update

DJ

Loe

4. dets 2025, 23:45 UTC

Market Talk

Nikkei May Decline Amid Caution Over U.S. Labor Market, Japan Earnings -- Market Talk

DJ

Loe

4. dets 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

4. dets 2025, 21:54 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

4. dets 2025, 21:54 UTC

Market Talk

Warehouse's Strategy to Lift Margins Easier Said Then Done -- Market Talk

DJ

Loe

4. dets 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Loe

4. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

4. dets 2025, 21:48 UTC

Market Talk

Scales Hits Mark With Earnings Guidance -- Market Talk

DJ

Loe

4. dets 2025, 21:37 UTC

Tulu

Aerospace Start-Up Beta Posts Its First Earnings Report. The Stock Rises. -- Barrons.com

DJ

Loe

4. dets 2025, 21:36 UTC

Tulu

These Stocks Moved the Most Today: Meta Platforms, Salesforce, Snowflake, UiPath, Micron, Dollar General, Kroger, and More -- Barrons.com

DJ

Loe

4. dets 2025, 20:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

4. dets 2025, 20:15 UTC

Market Talk

Think Tank Calls For Bank of Canada Rate Hold Next Week -- Market Talk

DJ

Loe

4. dets 2025, 20:04 UTC

Market Talk

Natural Gas Futures Extend Gains as U.S. Grows Cold -- Market Talk

DJ

Loe

4. dets 2025, 19:54 UTC

Market Talk

Oil Futures Bolstered by Lasting Ukraine War, U.S. Macro Outlook -- Market Talk

DJ

Loe

4. dets 2025, 19:44 UTC

Omandamised, ülevõtmised, äriostud

EQB CEO: PC Financial Deal Adds Scale to Compete With Larger Canadian Banks

DJ

Loe

4. dets 2025, 19:44 UTC

Omandamised, ülevõtmised, äriostud

EQB CEO: PC Financial Tie-Up Brings Scale to Reach More Customers

DJ

Loe

4. dets 2025, 19:44 UTC

Omandamised, ülevõtmised, äriostud

Equitable Bank Deal for PC Financial Adds Heft to Compete With Canada's Big Banks -- Interview

DJ

Loe

4. dets 2025, 19:33 UTC

Market Talk

Gold Inches Higher as Traders Continue to Mull ADP Jobs Report -- Market Talk

DJ

Loe

4. dets 2025, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Paramount Raises Concerns About Netflix's Bid for Warner Bros. Discovery -- WSJ

DJ

Loe

4. dets 2025, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Paramount Wrote to Warner Bros. Discovery Again Wednesday -- WSJ

DJ

Loe

4. dets 2025, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Paramount Wrote Netflix Deal With Warner Bros. Would Likely 'Never Close,' Monday Letter Says -- WSJ

DJ

Loe

4. dets 2025, 19:01 UTC

Omandamised, ülevõtmised, äriostud

Another Round of Bids for Warner Bros. Discovery Due Thursday, Sources Say -- WSJ

DJ

Loe

4. dets 2025, 18:58 UTC

Market Talk

U.S.-Venezuela Military Tension Expected to Lift Oil Prices -- Market Talk

DJ

Loe

4. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Loe

4. dets 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

4. dets 2025, 16:41 UTC

Market Talk

Gold Rises as Traders Await U.S. Inflation Data -- Market Talk

DJ

Loe

4. dets 2025, 16:33 UTC

Market Talk
Tulu

Salesforce Customers Are Gaining Confidence in Agentforce -- Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Oxford Biomedica PLC Prognoos

Hinnasiht

By TipRanks

12.81% tõus

12 kuu keskmine prognoos

Keskmine 708.438 GBX  12.81%

Kõrge 960.754 GBX

Madal 446.701 GBX

Põhineb 3 Wall Streeti analüütiku instrumendi Oxford Biomedica PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Põhineb 3 analüütiku instrumendi Oxford Biomedica PLC aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Muud aktsiad sektorist

AZN.UK

AstraZeneca PLC

13,576

↑ +0.76%

GSK

GlaxoSmithKline PLC

1,802

↓-1.56%
help-icon Live chat